These outcomes, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 assist the thought of focusing on ACKR3 as a unique solution to modulate the opioid system, which could open new therapeutic avenues for opioid-linked disorders. “In general, the discovery of https://michaelc478rnc5.ssnblog.com/profile